{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:31:50Z","timestamp":1787808710959,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with nonischemic dilated cardiomyopathy (NIDCM) are prone to arrhythmias, and the cause of mortality in these patients is either end-organ dysfunction due to pump failure or malignant arrhythmia-related death. However, the identification of patients with NIDCM at risk of malignant ventricular arrhythmias (VAs) is challenging in clinical practice. The aim of this study was to evaluate whether cardiovascular magnetic resonance feature tracking (CMR-FT) could help in the identification of patients with NIDCM at risk of malignant VAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 263 NIDCM patients who underwent CMR, 24-hour Holter electrocardiography (ECG) and inpatient ECG were retrospectively evaluated. The patients with NIDCM were allocated to two subgroups: NIDCM with VAs and NIDCM without VAs. From CMR-FT, the global peak radial strain (GPRS), global longitudinal strain (GPLS), and global peak circumferential strain (GPCS) were calculated from the left ventricle (LV) model. We investigated the possible predictors of NIDCM combined with VAs by univariate and multivariate logistic regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The percent LGE (15.51\u2009\u00b1\u20093.30 vs. 9.62\u2009\u00b1\u20092.18, P\u2009&lt;\u20090.001) was higher in NIDCM patients with VAs than in NIDCM patients without VAs. Furthermore, the NIDCM patients complicated with VAs had significantly lower GPCS than the NIDCM patients without VAs (\u2212\u20095.38 (\u2212\u20097.50, \u2212\u20094.22) vs.\u22129.22 (\u2212\u200910.73, \u2212\u20098.19), P\u2009&lt;\u20090.01). Subgroup analysis based on LGE negativity showed that NIDCM patients complicated with VAs had significantly lower GPRS, GPCS, and GPLS than NIDCM patients without VAs (P\u2009&lt;\u20090.05 for all). Multivariate analysis showed that both GPCS and %LGE were independent predictors of NIDCM combined with VAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CMR global strain can be used to identify NIDCM patients complicated with VAs early, specifically when LGE is not present. GPCS\u2009&lt;\u2009\u2212\u200913.19% and %LGE\u2009&gt;\u200910.37% are independent predictors of NIDCM combined with VAs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-023-03655-4","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T16:13:48Z","timestamp":1704298428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of patients with nonischemic dilated cardiomyopathy at risk of malignant ventricular arrhythmias: insights from cardiac magnetic resonance feature tracking"],"prefix":"10.1186","volume":"24","author":[{"given":"Hai-Yan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-You","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Zhuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Ju","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Pin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"3655_CR1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, ESC Scientific Document Group, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic Heart Failure. Eur Heart J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"2","key":"3655_CR2","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(09)62023-7","volume":"375","author":"JL Jefferies","year":"2010","unstructured":"Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet. 2010;375(2):752\u201362.","journal-title":"Lancet"},{"issue":"9","key":"3655_CR3","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jcmg.2013.05.013","volume":"6","author":"TG Neilan","year":"2013","unstructured":"Neilan TG, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ, et al. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2013;6(9):944\u201354.","journal-title":"JACC Cardiovasc Imaging"},{"key":"3655_CR4","doi-asserted-by":"crossref","unstructured":"Poyhonen P, Kivisto S, Holmstrom M, Hanninen H. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study. BMC Cardiovasc Disord. 2014(1);14:110.","DOI":"10.1186\/1471-2261-14-110"},{"issue":"1","key":"3655_CR5","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","volume":"135","author":"BP Halliday","year":"2017","unstructured":"Halliday BP, Gulati A, Ali A, Guha K, Newsome S, Arzanauskaite M, et al. Association between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation. 2017;135(1):2106\u201315.","journal-title":"Circulation"},{"issue":"11","key":"3655_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.cardfail.2014.08.005","volume":"20","author":"T Yamada","year":"2014","unstructured":"Yamada T, Hirashiki A, Okumura T, Adachi S, Shimazu S, Shimizu S, et al. Prognostic impact of combined late gadolinium enhancement on cardiovascular magnetic resonance and peak oxygen consumption in ambulatory patients with nonischemic dilated cardiomyopathy. J Card Fail. 2014;20(11):825\u201332.","journal-title":"J Card Fail"},{"issue":"10","key":"3655_CR7","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/j.hrthm.2015.05.026","volume":"12","author":"SR Piers","year":"2015","unstructured":"Piers SR, Everaerts K, van der Geest RJ, Hazebroek MR, Siebelink HM, Pison LA, et al. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. Heart Rhythm. 2015;12(10):2106\u201314.","journal-title":"Heart Rhythm"},{"issue":"3","key":"3655_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/jmri.1052","volume":"13","author":"O Strohm","year":"2001","unstructured":"Strohm O, Schulz-Menger J, Pilz B, Osterziel KJ, Dietz R, Friedrich MG. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J Magn Reson Imaging. 2001;13(3):367\u201371.","journal-title":"J Magn Reson Imaging"},{"issue":"25","key":"3655_CR9","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","volume":"67","author":"AG Japp","year":"2016","unstructured":"Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol. 2016;67(25):2996\u20133010.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3655_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/14779072.2019.1550719","volume":"17","author":"A Porcari","year":"2019","unstructured":"Porcari A, De Angelis G, Romani S, Paldino A, Artico J, Cannata A, et al. Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques. Expert Rev Cardiovasc Ther. 2019;17(1):53\u201363.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"3655_CR11","doi-asserted-by":"publisher","first-page":"e004077","DOI":"10.1161\/CIRCIMAGING.115.004077","volume":"9","author":"A Schuster","year":"2016","unstructured":"Schuster A, Hor KN, Kowallick JT, Beerbaum P, Kutty S. Cardiovascular magnetic resonance myocardial feature tracking: concepts and clinical applications. Circ Cardiovasc Imaging. 2016;9(4):e004077.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"3655_CR12","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jcmg.2015.11.001","volume":"8","author":"P Claus","year":"2015","unstructured":"Claus P, Omar AMS, Pedrizzetti G, Sengupta PP, Nagel E. Tissue Tracking Technology for assessing Cardiac mechanics: principles, normal values, and clinical applications. JACC Cardiovasc Imaging. 2015;8(12):1444\u201360.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"3655_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","volume":"90","author":"F Grothues","year":"2002","unstructured":"Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with Heart Failure or left ventricular hypertrophy. Am J Cardiol. 2002;90(1):29\u201334.","journal-title":"Am J Cardiol"},{"issue":"5","key":"3655_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/ehjci\/jev227","volume":"17","author":"M Obokata","year":"2016","unstructured":"Obokata M, Nagata Y, Wu VC, Kado Y, Kurabayashi M, Otsuji Y, et al. Direct comparison of cardiac magnetic resonance feature tracking and 2D\/3D echocardiography speckle tracking for evaluation of global left ventricular strain. Eur Heart J Cardiovasc Imaging. 2016;17(5):525\u201332.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"3655_CR15","first-page":"1","volume":"10","author":"X Linsheng Song","year":"2022","unstructured":"Linsheng Song X, Zhao. Wenlong Lv,Jie Zeng,Yishuang Wang, Bo Gong, preliminary study on the diagnostic value of cardiac magnetic resonance feature tracking for malignant ventricular arrhythmias in non-ischemic dilated cardiomyopathy. Ann Transl Med. 2022;10(4):1\u201311.","journal-title":"Ann Transl Med"},{"issue":"23","key":"3655_CR16","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial Diseases. Eur Heart J. 2016;37(23):1850\u20138.","journal-title":"Eur Heart J"},{"issue":"1","key":"3655_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12968-020-00607-1","volume":"22","author":"CM Kramer","year":"2020","unstructured":"Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22(1):17.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"3655_CR18","first-page":"539","volume":"105","author":"MD Cerqueira","year":"2002","unstructured":"Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, American Heart Association Writing Group on, Myocardial S, et al. Registration for Cardiac I. standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105(2):539\u201342.","journal-title":"Circulation"},{"issue":"2","key":"3655_CR19","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1111\/j.1540-8159.1997.tb06121.x","volume":"20","author":"J Brachmann","year":"1997","unstructured":"Brachmann J, Hilbel T, Grunig E, Benz A, Haass M, Kubler W. Ventricular arrhythmias in dilated cardiomyopathy. Pacing Clin Electrophysiol. 1997;20(2):2714\u20138.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"3655_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","volume":"5","author":"A Di Marco","year":"2017","unstructured":"Di Marco A, Anguera I, Schmitt M, Klem I, Neilan TG, White JA, et al. Late Gadolinium Enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and Meta-analysis. JACC Heart Fail. 2017;5(1):28\u201338.","journal-title":"JACC Heart Fail"},{"issue":"10","key":"3655_CR21","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","volume":"48","author":"RG Assomull","year":"2006","unstructured":"Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48(10):1977\u201385.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3655_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijcard.2010.11.005","volume":"157","author":"PG Masci","year":"2012","unstructured":"Masci PG, Barison A, Aquaro GD, Pingitore A, Mariotti R, Balbarini A, et al. Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy. Int J Cardiol. 2012;157(1):43\u20137.","journal-title":"Int J Cardiol"},{"issue":"25","key":"3655_CR23","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.jacc.2008.03.018","volume":"51","author":"KC Wu","year":"2008","unstructured":"Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008;51(25):2414\u201321.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3655_CR24","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.hrthm.2014.01.014","volume":"11","author":"M Perazzolo Marra","year":"2014","unstructured":"Perazzolo Marra M, De Lazzari M, Zorzi A, Migliore F, Zilio F, Calore C, et al. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and Sudden Cardiac Death in nonischemic dilated cardiomyopathy. Heart Rhythm. 2014;11(5):856\u201363.","journal-title":"Heart Rhythm"},{"issue":"2","key":"3655_CR25","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.jcmg.2018.07.015","volume":"12","author":"BP Halliday","year":"2019","unstructured":"Halliday BP, Baksi AJ, Gulati A, Ali A, Newsome S, Izgi C, et al. Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late Gadolinium Enhancement. JACC Cardiovasc Imaging. 2019;12(2):1645\u201355.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"3655_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCIMAGING.111.971549","volume":"5","author":"P Gao","year":"2012","unstructured":"Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P, et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging. 2012;5(4):448\u201356.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"9","key":"3655_CR27","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jama.2013.1363","volume":"309","author":"A Gulati","year":"2013","unstructured":"Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and Sudden Cardiac Death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309(9):896\u2013908.","journal-title":"JAMA"},{"issue":"2","key":"3655_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jacc.2010.07.043","volume":"57","author":"E Perez-David","year":"2011","unstructured":"Perez-David E, Arenal A, Rubio-Guivernau JL, Del Castillo R, Leonardo Atea E, Arbelo, et al. Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic Myocardial Infarction: comparison of signal intensity scar mapping and endocardial voltage mapping. J Am Coll Cardiol. 2011;57(2):184\u201394.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"3655_CR29","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.106.653568","volume":"115","author":"A Schmidt","year":"2007","unstructured":"Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced Cardiac Arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115(15):2006\u201314.","journal-title":"Circulation"},{"issue":"12","key":"3655_CR30","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/europace\/eut228","volume":"15","author":"M Disertori","year":"2013","unstructured":"Disertori M, Quintarelli S, Mazzola S, Favalli V, Narula N, Arbustini E. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Europace. 2013;15(12):1693\u2013701.","journal-title":"Europace"},{"issue":"1","key":"3655_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/01.CIR.0000078641.19365.4C","volume":"108","author":"JA McCrohon","year":"2003","unstructured":"McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, et al. Differentiation of Heart Failure related to dilated cardiomyopathy and coronary artery Disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108(1):54\u20139.","journal-title":"Circulation"},{"issue":"5","key":"3655_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s001470100339","volume":"14","author":"N De Leeuw","year":"2001","unstructured":"De Leeuw N, Ruiter DJ, Balk AH, de Jonge N, Melchers WJ, Galama JM. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int. 2001;14(5):299\u2013306.","journal-title":"Transpl Int"},{"issue":"1","key":"3655_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0022-2828(08)80028-4","volume":"27","author":"CA Beltrami","year":"1995","unstructured":"Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, et al. The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol. 1995;27(1):291\u2013305.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"3655_CR34","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0002-9149(98)00020-4","volume":"81","author":"TA Waller","year":"1998","unstructured":"Waller TA, Hiser WL, Capehart JE, Roberts WC. Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. Am J Cardiol. 1998;81(1):884\u201394.","journal-title":"Am J Cardiol"},{"issue":"2","key":"3655_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejrad.2012.11.012","volume":"82","author":"A Schuster","year":"2013","unstructured":"Schuster A, Morton G, Hussain ST, Jogiya R, Kutty S, Asrress KN, et al. The intra-observer reproducibility of cardiovascular magnetic resonance myocardial feature tracking strain assessment is Independent of field strength. Eur J Radiol. 2013;82(2):296\u2013301.","journal-title":"Eur J Radiol"},{"issue":"9","key":"3655_CR36","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.crad.2015.05.006","volume":"70","author":"A Schuster","year":"2015","unstructured":"Schuster A, Stahnke VC, Unterberg-Buchwald C, Kowallick JT, Lamata P, Steinmetz M, et al. Cardiovascular magnetic resonance feature-tracking assessment of myocardial mechanics: Intervendor agreement and considerations regarding reproducibility. Clin Radiol. 2015;70(9):989\u201398.","journal-title":"Clin Radiol"},{"issue":"4","key":"3655_CR37","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.21037\/qims-20-635","volume":"11","author":"JP Yang-Yang Qu","year":"2021","unstructured":"Yang-Yang Qu JP, Li H, Ma G-S, Buckert D, Rasche V. Left ventricular myocardial strain quantification with two-and three-dimensional cardiovascular magnetic resonance based tissue tracking. Quant Imaging Med Surg. 2021;11(4):1421\u201336.","journal-title":"Quant Imaging Med Surg"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03655-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T16:16:31Z","timestamp":1704298591000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03655-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3655"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03655-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2775329\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"4 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Guizhou Provincial People\u2019s Hospital (No. 2020\u2009\u2212\u2009387). Written informed consent for patients with NIDCM was waived by the Ethics Committee of Guizhou Provincial People\u2019s Hospital because this was a retrospective study. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}